XCUR
$1.58
Exicure
$.04
2.60%
XCUR
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.09)
Revenue:  $2.00 Mil
Thursday
Nov 5
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when XCUR reports earnings?
Beat
Meet
Miss

Where is XCUR's stock price going from here?
Up
Flat
Down
Stock chart of XCUR
Analysts
Summary of analysts' recommendations for XCUR
Score
Grade
Pivots
Resistance
$1.78
$1.72
$1.63

$1.57

Support
$1.48
$1.42
$1.33
Tweet
Growth
Description
Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.